Sildenafil Citrate Tablet
Product Images NDC 80425-0503

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 80425-0503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil 100mg #6 (Sildenafil 100mg 80425 0503 01)

SILDENAFIL CITRATE 100 mg oral tablet packaging label from Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0503-01, lot number, and expiration date 12/31/2026. It also mentions comparison to Viagra and storage instructions at 20°-25°C (68°-77°F). Barcode and prescription-only status are present.*

FDA Label Image

Sildenafil 100mg #12 (Sildenafil 100mg 80425 0503 02)

Label for Sildenafil Citrate 100 mg oral tablet by Advanced Rx of Tennessee, LLC. The label includes the product name and strength, NDC 80425-0503-02, and comparison to Viagra. Storage instructions specify 20°-25°C (68°-77°F). The label also includes lot and expiration date placeholders and states the product is Rx only.*

FDA Label Image

Sildenafil 100mg #30 (Sildenafil 100mg 80425 0503 03)

Label for Sildenafil Citrate 100 mg tablet by Advanced Rx of Tennessee, LLC. The label specifies a 30-tablet count with instructions to compare to Viagra. It includes storage information, a QR code, lot number placeholder, expiration date of 12/31/2026, barcode, and prescription only indication.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

A line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers. The x-axis represents time post dose in hours, and the y-axis represents systolic blood pressure change (mmHg). Two lines compare the effects of Sildenafil Citrate 100 mg and placebo.*

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

Line graph showing mean standing systolic blood pressure change from baseline over 8 hours postdose. Two data series compare Doxazosin plus placebo (blue line) and Doxazosin plus Sildenafil 25 mg (black line), illustrating blood pressure changes at various time points after dosing.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

A line chart showing mean standing systolic blood pressure change over time in hours. The chart compares two treatments: Doxazosin plus placebo and Doxazosin plus sildenafil 50 mg. The y-axis shows changes in systolic blood pressure in mmHg, and the x-axis indicates time postdose in hours from 0 to 8.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing blood pressure changes (mmHg) over time (hours) after dosing. Two lines represent groups: 'Doxazosin + Sildenafil 100 mg' and 'Doxazosin + Placebo', with measurements from 0 to 8 hours post-dose.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

A line graph showing the mean plasma concentrations of sildenafil over time in healthy male volunteers after treatment with a commercial tablet. The x-axis represents time post dose in hours, and the y-axis shows plasma concentration in ng/ml, illustrating a peak concentration shortly after dosing followed by a decline over 24 hours.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

Two bar graphs comparing the effect of sildenafil citrate and placebo on maintenance of erection by baseline score. The x-axis shows baseline scores from 0 to 5, and the y-axis represents the percentage of patients at endpoint, up to 80%. Each score category contains multiple bars with different shading, indicating various levels or groups.*

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

A bar graph showing the percentage of patients reporting improvement across different treatment groups: placebo, and sildenafil citrate at 25 mg, 50 mg, and 100 mg doses. The percentages increase from placebo to higher sildenafil citrate doses, with values of 24%, 63%, 74%, and 82% respectively.*

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

Chemical structure of sildenafil citrate, showing the molecular arrangement of atoms and bonds distinctive to the compound used in the drug product Sildenafil Citrate 100 mg tablet by Advanced Rx of Tennessee, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.